We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+6.6%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$3.3B
AUM Growth
+$481M
(+17%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
15.52%
Top 10 Holdings %
Top 10 Hldgs %
30.72%
Holding
1,380
New
403
Increased
148
Reduced
188
Closed
428
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$41.4M |
| 2 |
XLRN
Acceleron Pharma
XLRN
|
+$7.85M |
| 3 |
Bausch Health
BHC
|
+$7.4M |
| 4 |
Albemarle
ALB
|
+$6.62M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$6.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$24.4M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$10M |
| 3 |
Amgen
AMGN
|
+$7.37M |
| 4 |
Cracker Barrel
CBRL
|
+$5.6M |
| 5 |
Costco
COST
|
+$5.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.28% |
| 2 | Communication Services | 1.55% |
| 3 | Technology | 0.91% |
| 4 | Consumer Discretionary | 0.74% |
| 5 | Financials | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
201
DELISTED
Apellis Pharmaceuticals
APLS
| $3.3M | 0.1% |
100,000
+90,000
| +900% | +$5.06M |
|
202
CALL
LivaNova
LIVN
$4.45B
| $3.29M | 0.1% |
+41,500
| New | +$3.41M |
|
|
ARNA
203
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $3.27M | 0.1% |
+55,000
| New | +$3.25M |
|
204
Biogen
BIIB
$30.7B
| $3.25M | 0.1% |
+11,500
| New | +$3.77M |
|
205
CALL
West Pharmaceutical
WST
$23.9B
| $3.23M | 0.1% |
7,600
-8,800
| -54% | -$3.71M |
|
|
206
PUT
West Pharmaceutical
WST
$23.9B
| $3.23M | 0.1% |
7,600
-6,000
| -44% | -$2.53M |
|
207
Target
TGT
$65.6B
| $3.2M | 0.1% |
+14,000
| New | +$3.51M |
|
208
CALL
SL Green Realty
SLG
$3.81B
| $3.19M | 0.1% |
45,000
| – | – |
|
209
CALL
RTX Corp
RTX
$289B
| $3.18M | 0.1% |
+37,000
| New | +$3.16M |
|
210
PUT
Pinduoduo
PDD
$124B
| $3.17M | 0.1% |
35,000
-66,500
| -66% | -$6.47M |
|
211
Veeva Systems
VEEV
$32.7B
| $3.17M | 0.1% |
+11,000
| New | +$3.49M |
|
212
CALL
Incyte
INCY
$24.9B
| $3.1M | 0.09% |
45,000
+37,500
| +500% | +$2.85M |
|
|
213
PUT
Incyte
INCY
$24.9B
| $3.1M | 0.09% |
45,000
+37,500
| +500% | +$2.85M |
|
214
PUT
Advanced Micro Devices
AMD
$791B
| $3.09M | 0.09% |
30,000
| – | – |
|
|
VIP
215
PUT
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$38.8M
| $3.06M | 0.09% |
+12,000
| New | +$3.68M |
|
216
PUT
Whirlpool
WHR
$2.47B
| $3.06M | 0.09% |
15,000
| – | – |
|
|
IGMS
217
CALL
DELISTED
IGM Biosciences
IGMS
| $3.02M | 0.09% |
+46,000
| New | +$3.52M |
|
218
PUT
CRISPR Therapeutics
CRSP
$4.77B
| $3.02M | 0.09% |
27,000
+15,000
| +125% | +$1.88M |
|
219
PUT
Camping World
CWH
$400M
| $3.01M | 0.09% |
77,500
| – | – |
|
220
CALL
Cencora
COR
$60.7B
| $2.99M | 0.09% |
25,000
| – | – |
|
221
FIVE9
FIVN
$2.12B
| $2.96M | 0.09% |
+18,500
| New | +$3.38M |
|
222
CALL
Merck
MRK
$321B
| $2.95M | 0.09% |
+39,300
| New | +$2.99M |
|
223
Welltower
WELL
$170B
| $2.93M | 0.09% |
+35,600
| New | +$3.06M |
|
224
CALL
Credit Acceptance
CACC
$5.81B
| $2.93M | 0.09% |
+5,000
| New | +$2.72M |
|
225
PUT
Johnson Controls International
JCI
$87.8B
| $2.86M | 0.09% |
+42,000
| New | +$3.03M |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q3 2021 Portfolio in Review
As of Q3 2021, SG3 Management held 1,380 positions worth $3.3B, up 17% from $2.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
SG3 Management deployed $512M of net new capital in Q3 2021, opening 403 new positions and adding to 148 existing holdings. Its largest new stake was Alphabet (Google) Class C: 300,000 shares worth $40M.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.3% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was Bank of America, an estimated $4.85M trimmed.
- SG3 Management's largest Q3 2021 buy was Alphabet (Google) Class C: 300,000 shares worth $40M.
- SG3 Management added most to Bausch Health in Q3 2021, an estimated $7.4M increase.
- SG3 Management's biggest Q3 2021 reduction was Bank of America, cutting an estimated $4.85M.
- SG3 Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $24.4M.
- SG3 Management's ten largest holdings make up 31% of its $3.3B portfolio in Q3 2021.
- SG3 Management opened 403 new positions and closed 428 in Q3 2021.
- SG3 Management's portfolio value rose 17% quarter-over-quarter to $3.3B.
Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.